Last reviewed · How we verify
NCT04953182
Pain Modality Treatment After Hemorrhoidectomy
trial testing Pain scale registry in Pain, Acute in 5,335 participants. Completed in 30 May 2021.
31 December 2020
Quick facts
| Lead sponsor | Assuta Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 5,335 |
| Start date | 1 July 2016 |
| Primary completion | 31 December 2020 |
| Estimated completion | 30 May 2021 |
Drugs / interventions tested
- Pain scale registry
Conditions studied
- Pain, Acute — all drugs for Pain, Acute →
- Pain, Procedural — all drugs for Pain, Procedural →
Sponsor
Assuta Medical Center
Who can join
Eligibility, any sex, with Pain, Acute or Pain, Procedural. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hemorrhoidectomy is one of the operations that causes the greatest intensity of pain. Treatment of postoperative pain is essential for the well-being of the patient. Long-term use of opioids and different drugs can have unintended consequences. The objective is to corroborate which pain treatment modality is better in patients after hemorrhoidectomy.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Analysis of Two Treatment Modalities for Post-surgical Pain after Hemorrhoidectomy.
Susmallian S, Aviv I, Babis I, Segal E. · · 2024 · cited 2× · PMID 38982903 · DOI 10.21614/chirurgia.2024.v.119.i.3.p.247 -
Analgesics around the clock is better than the on-demand modality for pain treatment after hemorrhoid surgery
Susmallian S, Aviv I, Babis I, Segal E. · · 2022 · DOI 10.21203/rs.3.rs-2103633/v1
Verify or expand the search:
- PubMed search for NCT04953182
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pain, Acute
Currently open trials in the same condition.
- NCT07249827 — A Randomized Comparison Between 0.67 mcg/kg, 1 mcg/kg, and 1.33 mcg/kg of Perineural Dexmedetomidine for Ultrasound-Guid · Phase 2 · recruiting
- NCT07053774 — Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain · Phase 2 · recruiting
- NCT07009951 — Impact of Virtual Reality in Cardiac Electrophysiology · recruiting
- NCT06960317 — Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements · NA · recruiting
- NCT06754657 — CORA-Q15: Continuous vs. Single-injection Interscalene Block on QoR-15 in Outpatient Rotator Cuff Surgery · Phase 4 · recruiting
Other Assuta Medical Center trials
Trials by the same sponsor.
- NCT06950684 — Impact of Protein Supplementation and Resistance Training on Body Composition, Functional Parameters, Metabolic Adaptati · NA · not yet recruiting
- NCT05122013 — Remote Intervention for Weight Regain After Sleeve Gastrectomy · NA · completed
- NCT04741113 — The Effect of an Education Module to Reduce Weight Bias Among Healthcare Professionals in a Private Hospital Setting · NA · completed
- NCT04451499 — The Effect of Adding Smartphone-based Platform to the Bariatric Surgery Preparation Process · NA · completed
- NCT05134389 — Survey on GI and Nutritional Parameters Among OAGB Patients From Different Countries · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04953182 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assuta Medical Center
- Last refreshed: 7 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04953182.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing